DJIA 18,048.85 -77.27 -0.43%
NASDAQ 5,076.11 -21.86 -0.43%
S&P 500 2,111.90 -8.89 -0.42%
market minute promo


company name or ticker

Orexigen's Obesity Drug Contrave Faces Generic Threat - Analyst Blog

Orexigen - Contrave Sales Outpace Competition, But Are Still Not Enough

What Novo Nordisk's Entry Into The Obesity Space Means To The Sector

Today's Dead Cat Bounce Stock: Orexigen Therapeutics (OREX)

Orexigen Faces Generic Challenge For Anti-Obesity Drug

3 Promising Small-Caps Under $10 You Can Buy Right Now

These small-cap stocks might be just the thing you're looking for.

Don't Write Off Arena As Yet

3 Promising Healthcare Stocks Under $10

Healthcare stocks with plenty of potential -- and low share prices

7 Trends Drug Investors Should Know

Vivus Sales Remain Flat - Stock Trend Not Good

See More Articles...